ReviewOncotarget2022

Patient-derived tumor models are attractive tools to repurpose drugs for ovarian cancer treatment: pre-clinical updates.

Magdalena Cybula et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.